Jan Hartmann: NexSys Plasma Collection System Receives FDA Clearance
Jan Hartmann, Chief Medical Officer at Haemonetics, reposted from Haemonetics on LinkedIn:
”Exciting Next Step in Plasma Collection Innovation
Happy to share that the NexSys PCS Plasma Collection System with Persona PLUS technology has received FDA 510(k) clearance.
This milestone reflects an extraordinary cross‑functional effort.
Our submission was supported by a large, rigorous randomized controlled clinical trial involving nearly 3,000 plasma donors and more than 30,000 plasma collection procedures.
At its core, this work put donor safety first—carefully studying outcomes while advancing our personalized approach to plasma collection.
We saw increases in average plasma volume per donation, with no negative impact to safety, helping strengthen source plasma availability for life‑changing plasma‑derived medicinal products.
With global demand for these therapies continuing to grow, innovation that responsibly improves efficiency and yield matters more than ever.
Grateful to everyone who contributed to this important step forward—for donors, plasma collectors, and ultimately the patients who depend on these therapies.”
Stay updated with Hemostasis Today.
-
Oct 10, 2026, 17:58Archo Farzana Batool: Exploring Medical Writing Through an Article on Iron Deficiency Anemia
-
Oct 10, 2026, 17:53Assessing Frailty in Adults With Hemophilia – JTH
-
Oct 10, 2026, 17:52Fatma Sadeghi: Reducing Maternal Health Inequalities Through Nursing Advocacy
-
Oct 10, 2026, 17:50Grzegorz Hensler: How Apheresis Transformed Blood Cell Separation and Collection
-
Oct 10, 2026, 17:47Hemant K Sharma: Japan’s Universal Artificial Blood Research – A Potential Breakthrough in Transfusion Medicine
-
Oct 10, 2026, 17:40John Strouse: Learning About Bleeding Disorders and Sickle Cell Disease at FWGBD
-
Oct 10, 2026, 17:34Mae Caime: Speaking at the Annual Women’s Retreat for the Hemophilia Community in Florida
-
Oct 10, 2026, 17:30Chokri Ben Lamine: PNH beyond the Textbook Triad
-
Oct 10, 2026, 17:29Ruah Alyamany: Thrombosis and Anticoagulation in Hematological Malignancies at SOHO KSA 2026